CoreWeave: AI Infrastructure’s Undervalued Gem
Finance

CoreWeave: AI Infrastructure’s Undervalued Gem

authorBy Mariana Mazzucato
DateMay 16, 2026
Read time3 min
CoreWeave, a prominent player in AI infrastructure, demonstrates exceptional growth potential, backed by significant order backlogs and robust contracted capacities. This analysis delves into the strategic financial decisions, market positioning, and future outlook of CoreWeave, reiterating its strong investment appeal despite the inherent risks of rapid expansion.

Unlocking AI Potential: CoreWeave’s Strategic Edge in a Dynamic Market

Solidifying Future Revenue: CoreWeave’s Impressive Backlog and Contracted Capacity

CoreWeave's financial projections are significantly bolstered by its impressive $99.4 billion backlog. This substantial figure, combined with nearly sold-out capacity for fiscal year 2026 and over 75% contracted capacity for 2027, underpins management’s confidence in achieving an annualized revenue run-rate exceeding $30 billion by FY2027. This strong foundation ensures a predictable and robust revenue stream, setting a clear path for sustained growth.

Enhancing Profitability: Innovative GPU Pricing and Power Capacity Growth

A key driver of CoreWeave’s superior performance is its dynamic approach to GPU pricing, which leverages both older and newer generation GPUs. This strategy, coupled with an expanding power capacity, allows CoreWeave to optimize revenue generation and enhance its adjusted EBITDA margins. The ability to adapt pricing based on market demand and technological advancements is critical in the fast-evolving AI sector, giving CoreWeave a competitive edge.

Navigating Expansion: Addressing Capital Expenditure and Financial Risks

CoreWeave’s aggressive expansion, while promising, necessitates significant capital expenditures. This growth strategy has led to increased debt and some equity erosion, raising concerns about potential bottom-line pressures and delayed EPS profitability. However, these investments are strategic, aimed at scaling operations to meet overwhelming demand, and are expected to yield substantial long-term returns despite the short-term financial implications.

Market Valuation and Margin Outlook: An Attractive Investment Opportunity

Despite its rapid growth and market potential, CoreWeave’s stock currently trades at a compelling valuation, with an EV/Sales multiple of 7.24x. This discount, combined with a projected long-term adjusted EBITDA margin target of 70% – significantly surpassing the average of over 50% for hyperscalers – positions CoreWeave as an attractive investment. The company anticipates a bottoming of margins in FQ1 2026, followed by a sequential recovery as it begins to monetize its vast backlog more aggressively.

Reaffirming “Strong Buy”: CoreWeave’s Resilient Growth Trajectory

Considering CoreWeave’s strategic backlog, innovative pricing models, robust margin targets, and attractive valuation post-correction, the company maintains its "Strong Buy" rating. Its ability to navigate high growth while sustaining a competitive edge in the AI infrastructure market makes it a standout opportunity for investors seeking long-term value in the technology sector.

More Articles
Finance
Intel's Remarkable Revival: A Phoenix Rising in the AI Era
Intel Corporation has experienced an extraordinary turnaround, with its stock soaring over 400% in a year. The company's x86 architecture is proving crucial for the burgeoning AI agentic era, supported by strong competitive advantages in manufacturing capacity and yield. Strategic collaborations with tech giants like Google and potential partnerships with Apple, alongside an expanding CPU market, underscore Intel's pivotal role and foundry relevance. Despite these promising prospects, the current valuation, exceeding 100 times forward earnings, suggests caution, as the potential for a market correction remains a significant risk.
By Morgan HouselMay 16, 2026
Finance
Ironwood Pharmaceuticals: A Profitable Opportunity Still Exists Despite Recent Setbacks
Despite recent stock performance challenges and the departure of its CFO, Ironwood Pharmaceuticals (IRWD) maintains a 'Hold' rating. The company's key product, Linzess, continues to dominate the IBS-C and CIC therapy market, reporting strong Q1 FY2026 net sales and significant market share. Furthermore, Apraglutide presents a substantial growth opportunity, with Phase III trials set to commence, potentially tapping into a multi-billion dollar market. Ironwood's financial guidance for FY2026, including projected Linzess sales and adjusted EBITDA, suggests a stable outlook and upside potential.
By Suze OrmanMay 16, 2026
Finance
Coloplast: Reassessing Valuation Amidst Market Shifts
Coloplast's valuation has been recalibrated to a 20x P/E, with a target price of 490 DKK, reflecting a more realistic assessment after recent market premiumization adjustments. Despite challenges such as the Kerecis acquisition write-down, product recalls, and regulatory changes, the company's core strengths and stable product demand remain robust. Trading at a historically low sub-18x P/E with a 5.76% yield, Coloplast offers an attractive long-term growth potential of 12–13% annually until 2028, warranting a buy recommendation. Risks, including geopolitical tensions and margin pressures, appear to be already factored into its current valuation, balancing potential upsides with existing challenges.
By David RubensteinMay 16, 2026
Finance
Analyzing the Economic Impact of AI Capital Expenditure
This report examines the broader economic effects of significant AI infrastructure investments made by major technology companies. It introduces a multiplier model to quantify both direct and indirect financial gains across the entire AI ecosystem. By focusing on hyperscalers' substantial capital allocations to AI, the analysis aims to shed light on how these investments translate into profitability for various industry participants, extending beyond immediate suppliers to businesses leveraging AI technologies.
By Nouriel RoubiniMay 16, 2026
Finance
Utilities Sector: Investment Opportunities and Risks in May
This analysis provides a comprehensive overview of the utilities sector, highlighting the undervaluation of water utilities and the overvaluation of gas and electricity subsectors. It compares two major Utilities ETFs, VPU and XLU, examining their fees, valuation, growth, and risk metrics. The article also identifies specific utility stocks that are currently more attractively priced than their industry counterparts, offering insights for long-term investors and those seeking tactical opportunities.
By Strive MasiyiwaMay 16, 2026